COVID-19 and liver dysfunction: current ideas and new therapeutic strategies
The purpose of the review is to present an analysis of the literature data on the etiopathogenesis and therapy of liver diseases while Covid-19. Liver damage is common in patients with COVID-19, which can be caused by the direct cytopathic effect of the virus, an uncontrolled immune response, sepsis...
Saved in:
| Main Authors: | E. A. Lyalyukova, I. V. Dolgalev, E. N. Chernysheva, I. V. Druk, G. M. Konovalova, A. V. Lyalуukov |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Open Systems Publication
2021-06-01
|
| Series: | Лечащий Врач |
| Subjects: | |
| Online Access: | https://journal.lvrach.ru/jour/article/view/9 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Physical activity as a multitarget therapy for metabolically associated fatty liver disease
by: E. A. Lyalyukova, et al.
Published: (2022-02-01) -
Effect of SARS-CoV-2 infection on liver function in patients with hepatitis B
by: Tong Sun, et al.
Published: (2024-12-01) -
Dose determination of VV116 in COVID-19 patients with severe liver dysfunction: a case report
by: Jing Yang, et al.
Published: (2025-02-01) -
New approaches to diagnosis and management of patients with metabolic-associated steatotic liver disease with immune response to SARS-CоV-2
by: V.I. Didenko, et al.
Published: (2025-06-01) -
Correlation of SARS-CoV-2 Infection with Hepatitis and Liver Disorders
by: Kimia Kardani, et al.
Published: (2021-09-01)